“Richard Alpert, senior partner at Evergreen Investments, decide which of his two best employees for promotion to the post of managing vice president. Prefer Charlie Pace He first Daniel Faraday, but this decision had become less clear when heard Alpert conversation inadvertently office and learned that Pace took Adderall, a stimulant prescribed mainly for people with disorder attention deficit / hyperactivity disorder (ADHD). Pace did not have ADHD and apparently took the drug tricking a doctor. Alpert faces a number of issues, including whether it was fair or any other employee Faraday high performance is taken into account for promotion in favor of someone illegally boosted its performance with a substance that was not a medical necessity. ”
by
Jared Harris,
Jenny Mead
Source: Darden School of Business
8 pages.
Release: Aug 30, 2012. Prod #: UV6577-PDF-ENG
Evergreen business improvement solution
Related Case Solutions:
Evergreen Enhancement
Driving Towards a Disruption?
Schon Klinik: Eating Disorder Care
Livelihood Advancement Business School
Evergreen Executive Education LLC
Interface’s Evergreen Services Agreement
Tumi And The Doughty Hanson Value Enhancement Group (VEG)
Coromandel: Enhancement of Short-Term Finance
Evergreen Natural Markets 2012, Spanish Version
The Bombay Stock Exchange: Liquidity Enhancement Incentive Programmes